Last edition
News about "Novartis"
Novartis Presents Interim Analysis of atrasentan Phase III Data
Novartis has presented results from a pre-specified interim analysis of the Phase III ALIGN study of atrasentan, an investigational oral selective endothelin A (ETA) receptor antagonist, in patients with IgA nephropathy (IgAN).
Novartis | 28/05/2024 | By Aishwarya | 132
Novartis to Acquire Mariana Oncology to Expand RLT Pipeline
Novartis has decided to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies (RLTs) to treat cancers with high unmet patient needs.
Novartis | 04/05/2024 | By Aishwarya | 229
Novartis | 14/03/2023 | By Sudeep Soparkar | 349
Novartis | 15/11/2022 | By Sudeep Soparkar | 528
Novartis generics arm to invest 50 million euros to boost capacity in Europe
Sandoz is constructing a new three-floor building connected to its existing penicillin production facility in Kundl, Austria<br />
Novartis | 08/11/2022 | By Sudeep Soparkar | 281
Novartis to invest $300 M in biologics manufacturing and development operations
The company plans to establish a biologics hub at its Basel, Switzerland campus
Novartis | 14/09/2022 | By Sudeep Soparkar | 472
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy